Christopher Bowden

2017

In 2017, Christopher Bowden earned a total compensation of $2.3M as Chief Medical Officer at Agios Pharmaceuticals, a 32% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$233,571
Option Awards$1,639,353
Salary$449,174
Other$8,710
Total$2,330,808

Bowden received $1.6M in option awards, accounting for 70% of the total pay in 2017.

Bowden also received $233.6K in non-equity incentive plan, $449.2K in salary and $8.7K in other compensation.

Rankings

In 2017, Christopher Bowden's compensation ranked 4,774th out of 14,666 executives tracked by ExecPay. In other words, Bowden earned more than 67.4% of executives.

ClassificationRankingPercentile
All
4,774
out of 14,666
67th
Division
Manufacturing
1,692
out of 5,768
71st
Major group
Chemicals And Allied Products
496
out of 2,074
76th
Industry group
Drugs
382
out of 1,730
78th
Industry
Pharmaceutical Preparations
303
out of 1,329
77th
Source: SEC filing on April 18, 2018.

Bowden's colleagues

We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2017.

2017

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

2017

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2017

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2017

Steve Hoerter

Agios Pharmaceuticals

Chief Commercial Officer

News

In-depth

You may also like